BioLife Expects QR Stop-Bleeding Products To Dramatically Boost Revenues
This article was originally published in The Tan Sheet
Executive Summary
BioLife believes it can reach $5 mil. in FY 2003 sales driven by increased revenues from its UrgentQR stop-bleeding product and other similar offerings in the scab-forming powder line